Opinion: Wanted: better policies and incentives to revitalize R&D for new antimicrobial drugs
In the not-too-distant future that we could be facing — one with rampant, uncontrollable, multidrug-resistant microbes — a seemingly inconsequential infection could have the power to kill. Being admitted to a hospital may do more harm than good, as hospital-acquired infections become incurable. Modern medical procedures, such as organ transplants, chemotherapy, and even surgery, might no longer be possible.
For many patients and physicians, this future is already a reality.
